Search clinical trials for: AZD0328

Total 5 results

AstraZeneca

Completed

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

Healthy

Sweden
AstraZeneca

Terminated

Study to Asses Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of AZD0328 in Patients With Schizophrenia

Schizophrenia

United States
King's College London
AstraZeneca; Helse Stavanger HF; Michael J. Fox Foundation for Parkinson's Research and other collaborators

Withdrawn

Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug (PD-MIND)

Parkinson Disease | Mild Cognitive Impairment
AstraZeneca

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

Alzheimer's Disease

Sweden
AstraZeneca

Completed

Safety, Tolerability & PK of AZD0328 in Caucasian & Japanese

Healthy Volunteers

United Kingdom

3

Subscribe